2-Benzyloxycarbonylamino-3-(2-{(S)-2,5-dioxo-4-[3-(pyrimidin-2-ylamino)-propyl]-imidazolidin-1-yl}-acetylamino)-propionic acid anion

ID: ALA1160225

PubChem CID: 44296797

Max Phase: Preclinical

Molecular Formula: C23H27N7O7

Molecular Weight: 513.51

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CN1C(=O)N[C@@H](CCCNc2ncccn2)C1=O)NCC(NC(=O)OCc1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C23H27N7O7/c31-18(27-12-17(20(33)34)29-23(36)37-14-15-6-2-1-3-7-15)13-30-19(32)16(28-22(30)35)8-4-9-24-21-25-10-5-11-26-21/h1-3,5-7,10-11,16-17H,4,8-9,12-14H2,(H,27,31)(H,28,35)(H,29,36)(H,33,34)(H,24,25,26)/t16-,17?/m0/s1

Standard InChI Key:  LSRGWAWHLWBSEJ-BHWOMJMDSA-N

Molfile:  

     RDKit          2D

 37 39  0  0  0  0  0  0  0  0999 V2000
    2.7500   -0.4000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4917   -1.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0792    0.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6667   -1.1875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4125   -0.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3250   -0.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7250   -1.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5000    0.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9417   -1.2875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5375   -0.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0958   -0.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1417   -0.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9750   -1.8500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0958    0.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8083   -1.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0667    0.9125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9292   -0.4417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5417   -0.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2792    0.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9000   -0.2167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8792    0.6250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3375   -1.5792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9750   -1.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3833   -0.9917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1250   -1.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7375   -1.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5250    0.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6292   -0.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5208   -0.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8083    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7708   -0.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5167   -1.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5625   -2.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0125   -0.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1292   -2.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1792   -3.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9542   -2.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  1  0
  6 18  1  0
  7  9  1  0
  8  6  1  0
  9  6  1  0
 10  1  1  0
 11 24  1  0
 12 10  1  0
 13  2  2  0
 14 11  2  0
 15 11  1  0
 16  3  2  0
 17 12  1  0
 18 17  1  0
 19  8  1  0
 20  7  2  0
 21  8  2  0
 22  7  1  0
 23 12  2  0
 24 31  1  0
 25 22  1  0
 26 25  1  0
 27 29  1  0
  5 28  1  1
 29 15  2  0
 30 14  1  0
 31 34  1  0
 32 26  1  0
 33 26  2  0
 34 28  1  0
 35 32  2  0
 36 33  1  0
 37 36  2  0
  5  4  1  0
 30 27  2  0
 35 37  1  0
M  END

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 513.51Molecular Weight (Monoisotopic): 513.1972AlogP: 0.08#Rotatable Bonds: 13
Polar Surface Area: 191.95Molecular Species: ACIDHBA: 9HBD: 5
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.38CX Basic pKa: 4.47CX LogP: -1.12CX LogD: -3.85
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.18Np Likeness Score: -0.98

References

1. Peyman A, Wehner V, Knolle J, Stilz HU, Breipohl G, Scheunemann KH, Carniato D, Ruxer JM, Gourvest JF, Gadek TR, Bodary S..  (2000)  RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirements.,  10  (2): [PMID:10673106] [10.1016/s0960-894x(99)00661-7]

Source